Japan Lifeline to buy US transseptal device maker Cross Vascular for up to USD 4,734,000
Bitget2026/09/29 06:47- Japan Lifeline agreed to buy Cross Vascular, via wholly owned subsidiary JLL Med USA, making it an indirect wholly owned unit.
- Deal values Cross Vascular common shares at USD 4,734,000, including USD 734,000 at closing and up to USD 4,000,000 earn-out.
- Advisory fees and related costs estimated at JPY 234 million, taking total estimated outlay to about JPY 977 million.
- Signing and closing are scheduled for Sept. 30, 2026.
- JLL Med USA will inject USD 7,265,000 into Cross Vascular, lifting capital to USD 7,274,000 for debt payments, working capital.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Production Increase Falls Short, Layoffs First! Boeing (BA.US) Cuts 5% of Commercial Airplane Jobs, Delays 737 Monthly Production Target of 47 Aircraft to 2027
Stephanie Pope, head of Boeing's commercial airplanes division, informed employees in an internal memo on Monday that due to obstacles in increasing aircraft production, the division plans to cut 5% of its workforce.
After acquiring SpotHero, Uber (UBER.US) makes its debut in the parking sector with a parking space reservation feature, initially available in 15 U.S. cities
Uber has launched a brand new parking space reservation feature, which marks its first step in the parking sector following its acquisition of the parking app SpotHero earlier this year.
Arbitrum will welcome a new propAMM
Crypto prices
More
